Schroder Ventures Life Sciences has raised $402 million (€344m) for
its biotechnology investment fund, providing a signal that venture
capital may at last be turning its head back in the direction of
METabolic EXplorer, a French biotechnology company specialising in
the development and production of new biological processes for the
manufacturing of chemicals and pharmaceuticals, has bolstered its
scientific team with the appointment...
Swiss chemicals group Lonza has said that a new small-scale
production plant at its Visp site will come on stream in July and
will boost its services in the area of exclusive manufacturing of
GEA Filtration has introduced a microfiltration plant for the
PharmaChem industries that, it claims, can perform studies on the
full range of filtration technologies using all types of filter
Cambrex has initiated a project aimed at constructing a new
facility to accommodate four cGMP-compliant suites dedicated to
cell therapy manufacturing. The company said the expansion would
increase its manufacturing capacity by 100...
Just over a year after acquiring the FSG business from Vivendi for
$360 million (€307m), Pall Corp has reported a healthy hike in
fiscal third-quarter sales and profits and once again raised its
earnings forecast for 2003.
Akzo Nobel's Diosynth unit has signed a multi-year contract to
manufacture and supply the active pharmaceutical ingredient for
Pfizer's growth hormone receptor antagonist Somavert. The value of
the agreement was not disclosed,...
AstraZeneca has opened a new multi-million dollar research facility
in Bangalore, India, which will focus principally on finding new
treatments for tuberculosis, a disease which is diagnosed in about
8 million people worldwide each...